Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00750997 · ClinicalTrials.gov registry record

Hypertonic Modulation of Inflammation Following Injury

A clinical trial, sponsored by University of Washington.

Terminated
Registry status
119
Enrollment target

NCT00750997: Clinical Trial study, sponsored by University of Washington.

NCT00750997 is a clinical trial that was terminated before completion, run by University of Washington. The registered enrollment target is 119 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00750997 was terminated before completion, sponsored by University of Washington.

TERMINATED
Registry status
119 participants
Enrollment target

Study Summary

This project seeks to determine the effect of prehospital resuscitation with hypertonic saline vs. conventional crystalloids on the inflammatory response after injury. The leading cause of late mortality following injury is multiple organ dysfunction syndrome (MODS), which results from a dysfunctional inflammatory response after injury. Previous studies suggest that hypertonic saline may be beneficial by modulating this initial response and decreasing subsequent organ injury. This project takes advantage of a unique opportunity, afforded by an NIH-funded multi-center clinical trial of hypertonic resuscitation (conducted by the Resuscitation Outcomes Consortium), to obtain blood samples from patients enrolled in this trial to analyze inflammatory responses early after hypertonic vs. conventional resuscitation. This study was an ancillary study to the main randomized clinical trial and thus prospective observational in nature The proposed study will be carried out in experiments grouped in three Specific Aims: Aim 1 provides a thorough investigation of the immunomodulatory response following hypertonic resuscitation with regard to neutrophil, monocyte, and T cell responses at serial time points after injury and resuscitation. Aim 2 comprises experiments to investigate the mechanisms by which hypertonicity may alter inflammatory cell signaling. Aim 3 seeks to correlate the laboratory findings with clinical endpoints reflective of immune dysfunction including inflammation, organ failure, nosocomial infection, and sepsis. The investigators hypothesize that hypertonic resuscitation will be associated with modulation of the excessive inflammatory response seen after injury and thus will result in reduced rates of inflammatory organ injury.

Primary Outcome

several parameters of neutrophil activation were assessed

Interventions

  • DRUG hypertonic saline

Trial Details

FieldValue
Enrollment Target 119 participants
Start Date 2007-11
Est. Completion 2009-12
University of Washington

1,048 total trials

Why NCT00750997 stopped before completion

NCT00750997 is an observational study that tracks outcomes without assigning an intervention. The registered 119 participants enrollment target is mid-sized for trials with a published cap.

The record links to 0 conditions, and to 1 intervention - of which hypertonic saline is the first listed.

NCT00750997 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT00750997 about?

NCT00750997 is a clinical study titled "Hypertonic Modulation of Inflammation Following Injury". This project seeks to determine the effect of prehospital resuscitation with hypertonic saline vs. conventional crystalloids on the inflammatory response after injury. The leading cause of late mortality following injury is multiple organ dysfunction syndrome (MODS), which results from a dysfunction...

What is the current status of trial NCT00750997?

This trial is currently terminated. The enrollment target is 119 participants. The study started on 2007-11. Estimated completion is 2009-12.

What interventions are being tested in trial NCT00750997?

The interventions under investigation include: hypertonic saline (DRUG).

Who is sponsoring clinical trial NCT00750997?

This trial is sponsored by University of Washington, which has 1,048 total clinical trials registered on ClinicalTrials.gov.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT04870762 · 119 participants · Phase 2

    Customized 3D Printed Oral Stents During Head and Neck Radiotherapy

  • NCT05559853 · 119 participants

    Developing a New MRI Technique to Understand Changes in Brain Tumors After Treatment

  • NCT06564389 · 119 participants · Phase 1

    FIH Study to Evaluate the Tolerability of PF-07832837 in Healthy Adults and Patients

  • NCT06742801 · 119 participants · NA

    Onyx™ Liquid Embolic IDE Clinical Study

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00750997, the US trial registry maintained by the National Library of Medicine. NCT00750997 (mid enrollment · none site footprint · terminated) retrieved and formatted by PlainTrial, see methodology.